Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
     Ambuja Cements Q2 Exhibits a 22 percent YoY Decline in Standalone Profit to Rs 501 Cr

    Ambuja Cements Q2 Exhibits a 22% YoY Decline in Standalone Profit to Rs 501 Cr


    Finance Outlook India Team | Monday, 28 October 2024

    Ambuja Cements announced on Monday that its second quarter ended in September 2024 had a standalone net profit of Rs 501 crore, a 22% year-over-year (YoY) decline from the Rs 644 crore recorded in the same quarter last year.

    In contrast, revenue from operations climbed 6% year over year to Rs 4,213 crore during the July–September 2024 period from Rs 3,970 crore during the previous year.

    In the September quarter, operating EBITDA decreased 12% year over year to Rs 683 crore, while margins dropped to 16.2% within the same time frame.

    "We are happy to report again another consistent performance that is in line with our expansion plan and is establishing new efficiency standards.As the cornerstones of our business, we remain committed to innovation, digitization, customer satisfaction, and ESG," stated Ajay Kapur, Whole Time Director & CEO, Ambuja Cement.

    In terms of operations, the sales volume increased by 9% year over year to 14.2 million tons, while the cost of kiln fuel decreased by 13% to Rs 1.59 per thousand kcal. This was made feasible by the overall decline in fuel basket costs as well as the greater use of inexpensive imported Petcoke and E-auction coal.

    Ambuja declared during the quarter that it had signed a legally binding contract with Orient Cements to purchase 46.8% of the company. The company hopes to reach 100+ MTPA capacity by the end of current fiscal year when the acquisition is completed successfully.

    The operating cost for the quarter was Rs 4,497 PMT, a 4% YoY improvement. At the end of the second quarter, the company's total cash and cash equivalents were Rs 10,135 crore, which allowed it to accelerate future growth.

    Ambuja's consolidated business-level working capital is 33 days, which shows how quickly the money in receivables and inventory may be unblocked. "With our strong foothold across the nation, we are further expanding our footprint in new geographies in line with our vision," Kapur stated.

    Ambuja Cement's stock is up almost 5% on Monday, trading at Rs 578.8 on the NSE.



    Read More:

    ConvoZen Launches End-to-End Conversational AI

    India & France Revise Tax Treaty, Scrap MFN Clause, Ease Dividends

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25